I have a Personal Chair in maternal and perinatal epidemiology in the Institute of Health and Society. I held a Public Health National Career Scientist Award personal fellowship funded by the National Institute for Health Research from 2005-11. My research programme was entitled 'The contribution of maternal obesity, substance use, air pollution and the use of assisted reproductive technologies on the aetiology of congenital anomalies.'
• Academic Director, Regional Maternity Survey Office (RMSO)
• Secretary to the British Isles Network of congenital Anomaly Registers (BINOCAR)
• European Surveillance of Congenital Anomalies (EUROCAT) Register Lead
• NIHR Doctoral Fellowships Panel
• CSO/Scottish Office Clinical Training Fellowships Panel
• Newlife Medical & Scientific Review Committee
• Chair, Newcastle University Diversity Committee
• Faculty Fellowships Group – Science
• FMS Ethics Committee
BSc (Hons) Physiology, 1988, University of Edinburgh
PhD Behavioural Teratology, 1993, University of Edinburgh
Personal Readership in Maternal & Perinatal Epidemiology 2007-10
Principal Research Associate, Newcastle University 2004-2007
Senior Research Associate, Newcastle University 1996-2003
Research Associate, Newcastle University 1993-1996
Fellow of the Faculty of Public Health by distinction from 2012
NIHR National Public Health Career Scientist, 2005-11
European Science Foundation Visiting Fellowship
My research interests lie within the field of maternal and perinatal health, and include:
-descriptive epidemiology of congenital anomaly types
-influence of lifestyle on the risk of congenital anomalies
-effect of exposure to air pollution on fetal & perinatal outcomes
-assisted reproductive technologies and pregnancy outcome
I am Principal Investigator on a number of externally funded research projects.
Chair, IHS Research Strategy Group
I am currently supervising five PhD students
Current funding includes:
Heslehurst N, Rankin J, Rushton S. (2013-17) A lifecourse investigation of maternal ethnic group and pregnancy weight in the development of short- and long-term health outcomes for women and their offspring. MRC 1+3 PhD Studentship; £87,000.
Bell R, Newham J, Rankin J. (2013-14) Exposure to potentially teratogenic medications and outcome of pregnancy in women with type 1 and type 2 diabetes. Diabetes UK; £19,805.
Rankin J, Best KE. (2012-15) Survival and predictors of survival in children born with congenital heart defects. British Heart Foundation Non-clinical studentship; £101,681.
Rankin J. (2012-14) Surveillance of congenital anomalies in the North of England. Healthcare Quality Improvement Partnership/Public Health England; £300,400.
Salotti J, Tennant PWG, Windebank K, Rankin J. (2012-13) Histiocytic disorders in children with congenital anomalies; a population-based record linkage study. Newlife Foundation for Disabled Children; £14,899.
Heslehurst N, McColl E, Rankin J. (2012-15) The development and pilot of a guideline implementation intervention for maternal obesity management among midwives. NIHR Post-doctoral fellowship; £297,856.
Rankin J, McConachie H, Glinianaia SV, Embleton N. (2011-12) Can the KIDSCREEN questionnaire be used to measure quality of life in children born with congenital anomalies? NUTH Flexibility & Sustainability Fund; £50,295.
Kaner E, Rankin J, Hodgson M, Bristow K, McColl E, Deverill M, Howel D. (2011-14) Brief alcohol intervention to reduce risky drinking in pregnancy: a pilot randomised controlled trial. NIHR RfPB; £247,717.
Rankin J, Graham RH, Embleton N, Robson SC. (2011-13) Reproductive loss in multiple pregnancies: a qualitative study of parents’ and health professionals’ experiences. Tiny Lives; £110,469.
Draper E, Morris J, Rankin J, Kurinzcuk J. (2010-12) Surveillance of congenital anomalies in the UK. Healthcare Quality Improvement Partnership; £157,558.
EUROCAT (2010-13) European Surveillance of Congenital Anomalies. European Union- Joint Action; 3 million euros.
Graham R, Rankin J, Embleton N, Robson SC. (2010-11) Diversity in parent and staff perspectives towards neonatal palliative care. Department of Health- Children’s Palliative Care call; £37,868.
Bell R, Rankin J, Glinianaia S, Bilous R. (2010-11) Congenital anomalies in the offspring of women with type 1 and type 2 diabetes. Diabetes UK; £35,196.
Rankin J. (2009-12) Congenital anomaly surveillance by the Northern Congenital Abnormality Survey. Healthcare Quality Improvement Partnership; £408,367.
Rankin J. (2005-11) The role of obesity, drug use, air pollution and assisted conception in the aetiology of congenital anomalies. NIHR National Career Scientist Award (Personal fellowship); £283,009.